NVO News and Press, Novo Nordisk A/S From 05/25/24

2024-05-25 07:00:00 ET Summary Buying stocks at record highs doesn't necessarily mean lower returns, and can actually lead to higher returns in the short term. Valuations matter, but the metric used to evaluate them is important. Cash-adjusted valuations provide a more accurate pi...

2024-05-25 06:47:00 ET What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run. We asked three Motley Fool contributors to look among recently high-flying stocks for those that they believe could...

2024-05-24 16:16:00 ET More on Novo Nordisk Novo weight loss therapy cuts mortality risk in kidney disease SA Asks: Is Eli Lilly or Novo Nordisk a better investment? The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings C...

2024-05-24 15:00:53 ET More on the markets S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight SPY ETF: Momentum Is In The Cards Stocks have more room to run - Invesco's Kristina Hooper Big bear Mike Wilson changes tune a...

2024-05-24 10:40:44 ET More on Zealand Pharma Zealand Pharma A/S (ZLDPF) Q1 2024 Earnings Call Transcript Zealand Pharma: Survodutide Has Potential Beyond Obesity Treatment Zealand Pharma A/S (ZEAL) Q4 2023 Earnings Call Transcript Historical earnings data fo...

2024-05-24 09:17:15 ET Summary Medifast's financial performance is deteriorating rapidly due to the emergence of drug-weight loss competitors. The company reported a significant decline in revenue and earnings in Q1 2023. Medifast is laying off employees and may need to furthe...

2024-05-24 07:06:38 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript SA Asks: Is Eli Lilly or Novo Nordisk a better in...

2024-05-23 14:07:59 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic FDA reviewers voice concerns o...

2024-05-22 13:32:00 ET Summary Australia to ban compounded versions of Novo Nordisk's semaglutide and Eli Lilly's tirzepatide due to safety concerns. Existing home sales dipped 1.89% in April to 4.14 million. All eyes on Nvidia earnings but BofA points to another stock that de...

2024-05-22 11:25:25 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Novo Nordisk office building fire brought under c...